Kestra Medical Technologies (KMTS) Research & Development (2024 - 2026)
Kestra Medical Technologies (KMTS) posted quarterly Research & Development of $5.6 million for Q2 2026, up 4.6% year-over-year from $5.4 million in Q2 2025, and up 13.31% quarter-over-quarter from $5.0 million in Q1 2026.
Kestra Medical Technologies (KMTS) Research & Development (2024 - 2026) Analysis & Trends
Kestra Medical Technologies (KMTS) has reported Research & Development for 3 consecutive years, with $5.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Research & Development rose 4.6% year-over-year to $5.6 million; the TTM figure through Apr 2026 stood at $19.5 million (up 24.49% YoY), while the FY2026 annual figure was $19.5 million, up 24.48% from the prior year.
- Research & Development rose to $5.6 million in Q2 2026 per KMTS's latest filing, from $5.0 million in the prior quarter.
- Across five years, Research & Development topped out at $5.6 million in Q2 2026 and bottomed at $3.4 million in Q1 2025.
- Historically, Research & Development has averaged $4.3 million across 3 years, with a median of $3.9 million in 2024.
- Annual changes were most pronounced in 2025 — Research & Development decreased 10.23% — and 2026, when it soared 48.29%.
- Kestra Medical Technologies' Research & Development stood at $3.5 million in 2024, then surged by 39.01% to $4.9 million in 2025, then grew by 15.5% to $5.6 million in 2026.
- Business Quant data shows KMTS's Research & Development at $5.6 million in Q2 2026, $5.0 million in Q1 2026, and $4.9 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.61 Bn | 129.40 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 52.47 Bn | 51.61 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.80 Bn | 34.45 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.87 Bn | 32.41 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 28.89 Bn | 26.21 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.07 Bn | 24.63 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.33 Bn | 14.92 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.85 Bn | 14.71 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Kestra Medical Technologies | 1.47 Bn | 1.11 Bn | 15.68 Mn | 5.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 5.63 Mn |
| Jan 31, 2026 | 4.97 Mn |
| Oct 31, 2025 | 4.88 Mn |
| Jul 31, 2025 | 4.00 Mn |
| Apr 30, 2025 | 5.39 Mn |
| Jan 31, 2025 | 3.35 Mn |
| Oct 31, 2024 | 3.51 Mn |
| Jul 31, 2024 | 3.40 Mn |
| Apr 30, 2024 | 3.82 Mn |
| Jan 31, 2024 | 3.74 Mn |